Genentech

HEMLIBRA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / HEMLIBRA – J7170

Manufacturer:

Genentech

Name:

HEMLIBRA

HCPCS Code Descriptor:

Injection, emicizumab-kxwh, 0.5 mg

Category:

J Code

HCPCS:

J7170

NDC(s):

50242-0923-01, 50242-0921-01, 50242-0922-01, 50242-0920-01

Primary Type:

Hematology

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

HEMLIBRA is a Hematology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J7170 is aligned to the drug HEMLIBRA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/19

HCPCS Effective Date:

1/1/19

HCPCS Short Description:

Inj., emicizumab-kxwh 0.5 mg

Billing and Coding Guide:

https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/Hemlibra-Billing-Coding-for-Hemophilia-A.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation